Inhibition of epidermal growth factor receptor restores decidualization markers in stromal fibroblasts from women with endometriosis

Journal of Endometriosis and Pelvic Pain Disorders

Volumn 6, Issue 4, 2014, Pages 196-211

  Erikson, David W ^a   Chen, Joseph C ^a   Piltonen, Terhi T ^a,b   Conti, Marco ^a   Irwin, Juan C ^a   Giudice, Linda C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

Decidualization; Endometriosis; Epidermal growth factor receptor; Fibroblast; Mammalian target of rapamycin; Mitogen activated protein kinase

Indexed keywords

8 BROMO CYCLIC AMP; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN; RAPAMYCIN; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR FKHR; UO 126;

ARTICLE; CLINICAL ARTICLE; DECIDUALIZATION; ENDOMETRIOSIS; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MULTIPLEX POLYMERASE CHAIN REACTION; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; YOUNG ADULT;

EID: 84920889137     PISSN: 22840265     EISSN: 22840273     Source Type: Journal    
DOI: 10.5301/je.5000198     Document Type: Article

References (36)

1. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389-2398.
2. Velarde MC, Aghajanova L, Nezhat CR, Giudice LC. Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3′,5′-cyclic adenosine 5′-monophosphate inhibition of cyclin D 1. Endocrinology. 2009;150(10):4701-4712.
3. Gerbie AB, Merrill JA. Pathology of endometriosis. Clin Obstet Gynecol. 1988;31(4):779-786.
4. Papaleo E, Ottolina J, Viganò P, et al Deep pelvic endometriosis negatively affects ovarian reserve and the number of oocytes retrieved for in vitro fertilization. Acta Obstet Gynecol Scand. 2011;90(8):878-884.
5. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83(1-5): 149-155.
6. Aghajanova L, Velarde MC, Giudice LC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010;28(1):51-58.
7. Alvarez P, Chen X, Hendrich J, et al. Ectopic uterine tissue as a chronic pain generator. Neuroscience. 2012;225:269-282.
8. Kim JJ, Yin X. Signaling pathways in endometriosis (eutopic/ ectopic). In: Giudice LC, Evers JLH, Healy DL, eds. Endometriosis: science and practice. Oxford, UK: Blackwell. 2012; 164-172.
9. Honda H, Barrueto FF, Gogusev J, Im DD, Morin PJ. Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles.for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol. 2008;6(1):59.
10. Yagyu T, Tsuji Y, Haruta S, et al. Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis. Int J Gynecol Cancer. 2006;16(4):1545-1551.
11. Laudanski P, Szamatowicz J, Kowalczuk O, Kuźmicki M, Grabowicz M, Chyczewski L. Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. Hum Reprod. 2009;24(8):1880-1890.
12. Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci. 2011;18(3):229-251.
13. Ejskjaer K, Sorensen BS, Poulsen SS, Mogensen O, Forman A, Nexo E. Expression of the epidermal growth factor system in eutopic endometrium from women with endometriosis differs from that in endometrium from healthy women. Gynecol Obstet Invest. 2009;67(2):118-126.
14. Aghajanova L, Horcajadas JA, Weeks JL, et al. The protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts reveals compromised differentiation and persistent proliferative potential in endometriosis. Endocrinology. 2010;151(3):1341-1355.
15. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril. 2006;85(3): 564-572.
16. Yin X, Pavone ME, Lu Z, Wei J, Kim JJ. Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis. J Clin Endocrinol Metab. 2012;97(1):E35-E43.
17. American Society for Reproductive. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817-821.
18. Tulac S, Overgaard MT, Hamilton AE, Jumbe NL, Suchanek E, Giudice LC. Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab. 2006;91(4):1453-1461.
19. Aghajanova L, Velarde MC, Giudice LC. The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis. Endocrinology. 2009;150(8):3863-3870.
20. Yamamoto T, Cui XM, Shuler CF. Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion. Dev Biol. 2003;260(2):512-521.
21. Gong HC, Wang S, Mayer G, et al. Signatures of drug sensitivity in nonsmall cell lung cancer. Int J Proteomics. 2011;2011:215496.
22. Eum KH, Lee M. Targeting the autophagy pathway using ectopic expression of Beclin 1 in combination with rapamycin in drug-resistant v-Ha-ras-transformed NIH 3T3 cells. Mol Cells. 2011;31(3):231-238.
23. L arionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics. 2005;6(1):62.
24. Chen JC, Frankshun AL, Wiley AA, et al. Milk-borne lactocrine- acting factors affect gene expression patterns in the developing neonatal porcine uterus. Reproduction. 2011; 141(5):675-683.
25. Sakamoto T, Tanaka T, Umesaki N, Ogita S. Epidermal growth factor inhibits 8-Br-cAMP-induced decidualization of human endometrial stromal cells. Horm Res. 2000;53(6): 294-299.
26. Aghajanova L, Tatsumi K, Horcajadas JA, et al. Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011;84(4):801-815.
27. Huang JC, Yeh J. Quantitative analysis of epidermal growth factor receptor gene expression in endometriosis. J Clin Endocrinol Metab. 1994;79(4):1097-1101.
28. Mellor SJ, Thomas EJ. The actions of estradiol and epidermal growth factor in endometrial and endometriotic stroma in vitro. Fertil Steril. 1994;62(3):507-513.
29. Burney RO, Talbi S, Hamilton AE, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8):3814-3826.
30. Talbi S, Hamilton AE, Vo KC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normoovulatory women. Endocrinology. 2006;147(3):1097-1121.
31. Jeong JW, Lee HS, Lee KY, et al. Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease. Proc Natl Acad Sci USA. 2009;106(21):8677-8682.
32. Jin N, Cho SN, Raso MG, et al. Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis. Development. 2009;136(19):3347-3356.
33. Xu Y, Tan LJ, Grachtchouk V, Voorhees JJ, Fisher GJ. Receptor-type protein-tyrosine phosphatase-kappa regu lates epidermal growth factor receptor function. J Biol Chem. 2005; 280(52):42694-42700.
34. Ciardiello F, Tortora G. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clin Cancer Res. 1998;4(4):821-828.
35. Blancquaert S, Wang L, Paternot S, et al. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol. 2010;24(7):1453-1468.
36. Evers JLH. Medical therapy of endometriosis: subfertility. In: Giudice LC, Evers JLH, Healy DL, eds. Endometriosis: science and practice. Oxford, UK: Blackwell. 2013;449-454.